Abstract
No overall increased risk of lymphoma associated with antibodies to human herpesvirus-8 was found in 526 lymphomas and 599 controls (odds ratio (OR)=1.04, 95% confidence interval (CI)=0.62-1.75); significant increases were noted for 19 lymphoplasmacytic lymphomas (OR=4.47, 95% CI=1.34-14.85) and nine low-grade lymphoma/lymphoma B-cell NOS (OR=5.82, 95% CI=1.07-31.73).
Publication types
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Adult
-
Aged
-
Case-Control Studies
-
DNA, Viral / analysis
-
Female
-
Herpesviridae Infections / complications*
-
Herpesvirus 8, Human / pathogenicity*
-
Humans
-
Incidence
-
Lymphoma, B-Cell / virology*
-
Male
-
Middle Aged
-
Odds Ratio
-
Polymerase Chain Reaction
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / virology*
-
Spain